LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2013

Apr 15, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2013-04-09

Reporting Person: ALLINGHAM DENNIS J (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-04-09	Common Stock	M	25000	$5.63	Acquired	25000	Direct
2013-04-10	Common Stock	M	16147	$5.63	Acquired	41147	Direct
2013-04-10	Common Stock	M	15103	$5.63	Acquired	56250	Direct
2013-04-09	Common Stock	S	25000	$13.62	Disposed	31250	Direct
2013-04-10	Common Stock	S	16147	$13.85	Disposed	15103	Direct
2013-04-10	Common Stock	S	15103	$13.847	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-04-09	Right to buy Incentive stock options	$5.63	M	25000	Disposed	2017-05-26	Common Stock (25000)	Direct
2013-04-10	Right to buy Incentive stock options	$5.63	M	16147	Disposed	2017-05-26	Common Stock (16147)	Direct
2013-04-10	Right to buy Nonqualified stock option	$5.63	M	15103	Disposed	2017-05-26	Common Stock (15103)	Direct

Footnotes

F1: Includes option that have not yet vested but will become fully vested on May 26, 2013.

F2: On May 27, 2010 the filed Form 3 incorrectly reported the acquisition of 60,000 incentive stock options, which should have been reported as 44,897 incentive stock options and 15,103 non-qualified stock options.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.50 to $13.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.